Kyle Gano
CIK: 0001567160
Transaction Breakdown
High conviction signal
Position reduction
Derivative conversions
Compensation grants
Gifts, tax withholding, conversions, dispositions to the issuer and other codes
Companies & Roles (1)
NEUROCRINE BIOSCIENCES INC
Discretionary Trading P&L
Holdings
Transaction History (38 total)
- Nov 1, 2026NBIX
NEUROCRINE BIOSCIENCES INC
Exercise(M)Direct614 shares- - Nov 1, 2026NBIX
NEUROCRINE BIOSCIENCES INC
Tax Payment(F)Direct332 shares at avg. $146.10$49K - Sep 11, 2026NBIX
NEUROCRINE BIOSCIENCES INC
Award(A)Direct1.8K shares- - Sep 11, 2026NBIX
NEUROCRINE BIOSCIENCES INC
Tax Payment(F)Direct994 shares at avg. $156.22$155K - Sep 11, 2026NBIX
NEUROCRINE BIOSCIENCES INC
Tax Payment(F)Direct3.4K shares at avg. $156.22$529K - Sep 11, 2026NBIX
NEUROCRINE BIOSCIENCES INC
Award(A)Direct6.3K shares- - Feb 13, 2026NBIX
NEUROCRINE BIOSCIENCES INC
Tax Payment(F)Direct1.4K shares at avg. $124.12$172K - Feb 13, 2026NBIX
NEUROCRINE BIOSCIENCES INC
Exercise(M)Direct2.2K shares- - Feb 13, 2026NBIX
NEUROCRINE BIOSCIENCES INC
Tax Payment(F)Direct1.2K shares at avg. $124.12$150K - Feb 13, 2026NBIX
NEUROCRINE BIOSCIENCES INC
Exercise(M)Direct2.6K shares- - Feb 13, 2026NBIX
NEUROCRINE BIOSCIENCES INC
Award(A)Direct10K shares- - Feb 13, 2026NBIX
NEUROCRINE BIOSCIENCES INC
Tax Payment(F)Direct5.4K shares at avg. $124.12$668K - Feb 12, 2026NBIX
NEUROCRINE BIOSCIENCES INC
Exercise(M)Direct4.9K shares- - Feb 12, 2026NBIX
NEUROCRINE BIOSCIENCES INC
Tax Payment(F)Direct2.6K shares at avg. $123.10$326K - Jan 31, 2026NBIX
NEUROCRINE BIOSCIENCES INC
Exercise(M)Direct2.9K shares- - Jan 31, 2026NBIX
NEUROCRINE BIOSCIENCES INC
Tax Payment(F)Direct1.6K shares at avg. $136.06$215K - Jan 16, 2026NBIX
NEUROCRINE BIOSCIENCES INC
Sale(S)Direct1.8K shares at avg. $132.71$240K - Jan 16, 2026NBIX
NEUROCRINE BIOSCIENCES INC
Exercise(M)Direct1.8K shares at avg. $35.99$65K - Jan 16, 2026NBIX
NEUROCRINE BIOSCIENCES INC
Exercise(M)Direct34.6K shares at avg. $35.99$1.2M - Jan 16, 2026NBIX
NEUROCRINE BIOSCIENCES INC
Sale(S)Direct34.6K shares at avg. $132.70$4.6M - Nov 4, 2025NBIX
NEUROCRINE BIOSCIENCES INC
Sale(S)Direct300 shares at avg. $141.97$43K - Nov 1, 2025NBIX
NEUROCRINE BIOSCIENCES INC
Exercise(M)Direct613 shares- - Feb 13, 2025NBIX
NEUROCRINE BIOSCIENCES INC
Sale(S)Direct1.4K shares at avg. $116.84$158K - Feb 13, 2025NBIX
NEUROCRINE BIOSCIENCES INC
Exercise(M)Direct2.6K shares- - Feb 13, 2025NBIX
NEUROCRINE BIOSCIENCES INC
Exercise(M)Direct2.2K shares-
| Type | Shares | Price | Ownership | |||
|---|---|---|---|---|---|---|
| Nov 1, 2026 | NBIX NEUROCRINE BIOSCIENCES INC | Exercise(M) | 614 | - | $0 | Direct |
| Nov 1, 2026 | NBIX NEUROCRINE BIOSCIENCES INC | Tax Payment(F) | 332 | $146.10 | $48,505 | Direct |
| Sep 11, 2026 | NBIX NEUROCRINE BIOSCIENCES INC | Award(A) | 1,842 | - | $0 | Direct |
| Sep 11, 2026 | NBIX NEUROCRINE BIOSCIENCES INC | Tax Payment(F) | 994 | $156.22 | $155,283 | Direct |
| Sep 11, 2026 | NBIX NEUROCRINE BIOSCIENCES INC | Tax Payment(F) | 3,386 | $156.22 | $528,961 | Direct |
| Sep 11, 2026 | NBIX NEUROCRINE BIOSCIENCES INC | Award(A) | 6,275 | - | $0 | Direct |
| Feb 13, 2026 | NBIX NEUROCRINE BIOSCIENCES INC | Tax Payment(F) | 1,385 | $124.12 | $171,906 | Direct |
| Feb 13, 2026 | NBIX NEUROCRINE BIOSCIENCES INC | Exercise(M) | 2,241 | - | $0 | Direct |
| Feb 13, 2026 | NBIX NEUROCRINE BIOSCIENCES INC | Tax Payment(F) | 1,210 | $124.12 | $150,185 | Direct |
| Feb 13, 2026 | NBIX NEUROCRINE BIOSCIENCES INC | Exercise(M) | 2,566 | - | $0 | Direct |
| Feb 13, 2026 | NBIX NEUROCRINE BIOSCIENCES INC | Award(A) | 9,968 | - | $0 | Direct |
| Feb 13, 2026 | NBIX NEUROCRINE BIOSCIENCES INC | Tax Payment(F) | 5,378 | $124.12 | $667,517 | Direct |
| Feb 12, 2026 | NBIX NEUROCRINE BIOSCIENCES INC | Exercise(M) | 4,907 | - | $0 | Direct |
| Feb 12, 2026 | NBIX NEUROCRINE BIOSCIENCES INC | Tax Payment(F) | 2,648 | $123.10 | $325,969 | Direct |
| Jan 31, 2026 | NBIX NEUROCRINE BIOSCIENCES INC | Exercise(M) | 2,927 | - | $0 | Direct |
| Jan 31, 2026 | NBIX NEUROCRINE BIOSCIENCES INC | Tax Payment(F) | 1,580 | $136.06 | $214,975 | Direct |
| Jan 16, 2026 | NBIX NEUROCRINE BIOSCIENCES INC | Sale(S) | 1,812 | $132.71 | $240,478 | Direct |
| Jan 16, 2026 | NBIX NEUROCRINE BIOSCIENCES INC | Exercise(M) | 1,812 | $35.99 | $65,214 | Direct |
| Jan 16, 2026 | NBIX NEUROCRINE BIOSCIENCES INC | Exercise(M) | 34,588 | $35.99 | $1,244,822 | Direct |
| Jan 16, 2026 | NBIX NEUROCRINE BIOSCIENCES INC | Sale(S) | 34,588 | $132.70 | $4,589,980 | Direct |
| Nov 4, 2025 | NBIX NEUROCRINE BIOSCIENCES INC | Sale(S) | 300 | $141.97 | $42,591 | Direct |
| Nov 1, 2025 | NBIX NEUROCRINE BIOSCIENCES INC | Exercise(M) | 613 | - | - | Direct |
| Feb 13, 2025 | NBIX NEUROCRINE BIOSCIENCES INC | Sale(S) | 1,352 | $116.84 | $157,974 | Direct |
| Feb 13, 2025 | NBIX NEUROCRINE BIOSCIENCES INC | Exercise(M) | 2,566 | - | - | Direct |
| Feb 13, 2025 | NBIX NEUROCRINE BIOSCIENCES INC | Exercise(M) | 2,241 | - | - | Direct |
1-25 of 38 transactions
About Gano Kyle
Gano Kyle (SEC CIK 0001567160) files insider reports with the SEC as Chief Executive Officer of NEUROCRINE BIOSCIENCES INC (NBIX).
Signal8 holds 11 ownership filings by Gano Kyle, all Form 4s, filed between Nov 1, 2024 and Nov 3, 2026. Those filings report 38 transactions, from Nov 1, 2024 to Nov 1, 2026. Signal8's Form 4 history starts in Sep 2024.
The business address on Gano Kyle's filings is in SAN DIEGO, CA.
Recent filings by Gano Kyle
- Nov 1, 2026: Option exercise of NBIX shares (Form 4, code M).
- Nov 1, 2026: Tax withholding of NBIX shares (Form 4, code F).
- Sep 11, 2026: Grant or award of NBIX shares (Form 4, code A).
- Sep 11, 2026: Tax withholdings of NBIX shares (2 lines, Form 4, code F).
- Sep 11, 2026: Grant or award of NBIX shares (Form 4, code A).
Other insiders filing for NEUROCRINE BIOSCIENCES INC (NBIX)
- MORROW GEORGE J, Director
- ROBERTS EIRY, Chief Medical Officer
- Onyia Jude, Chief Scientific Officer
- Lippoldt Darin, Chief Legal Officer
- Keswani Sanjay Chandru, Chief Medical Officer
- GORMAN KEVIN CHARLES, Director